Scopoderm and convulsion Patient Reports February 12, 2012

Scopoderm Side Effects Report #6037783-3
Scopoderm side effect was reported by a Physician from UNITED KINGDOM on Jan 08, 2009. Male patient, 67 years of age, was diagnosed with salivary hypersecretion and was treated with Scopoderm. After drug was administered, patient experienced the following side effects: convulsion, incorrect dose administered, off label use, somnolence. Scopoderm dosage: 105 MG, TRANSDERMAL. During the same period patient was treated with VALPROATE, MEMANTINE. Patient recovered.

Scopoderm Side Effects Report #5589424-7
Scopoderm side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 28, 2007. Male patient, 22 years of age, was diagnosed with salivary hypersecretion and was treated with Scopoderm. After drug was administered, patient experienced the following side effects: application site erythema, application site irritation, convulsion, off label use, purulence, wound secretion. Scopoderm dosage: unknown. During the same period patient was treated with GLUTAMINE, ASCORBIC ACID, PYRIDOXINE, ACIDIPHILUS, CLONAZEPAM, PHENYTOIN, ZONEGRAN, GLYCERIN SUPPOSITORIES. Patient recovered.

Scopoderm Side Effects Report #6028020-4
Scopoderm side effect was reported by a Health Professional from UNITED KINGDOM on Dec 16, 2008. Male patient was diagnosed with salivary hypersecretion and was treated with Scopoderm. After drug was administered, patient experienced the following side effects: convulsion, incorrect dose administered, off label use. Scopoderm dosage: 1.5 MG, UNK, TRANSDERMAL, 1.5MG, UNK, TRANSDERMAL. During the same period patient was treated with SCOPODERM TTS, VALPROATE. Patient recovered.

Scopoderm Side Effects Report #5082166-6
Scopoderm side effect was reported by a Health Professional from FRANCE on Aug 02, 2006. Male patient, weighting 24.25 lb, was treated with Scopoderm. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, convulsion, cytolytic hepatitis, disseminated intravascular coagulation, hyperthermia malignant, hypokalaemia, laboratory test abnormal. Scopoderm dosage: unknown. During the same period patient was treated with ESOMEPRAZOLE, MOTILIUM, ATARAX, UVESTEROL. Patient was hospitalized and became disabled. Patient recovered.